| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1518 | 2006 |
| Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte, ... Aids 17 (8), 1179-1193, 2003 | 1414 | 2003 |
| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... The Lancet 384 (9939), 241-248, 2014 | 1175 | 2014 |
| Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse … SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ... The Journal of infectious diseases 201 (3), 318-330, 2010 | 858 | 2010 |
| Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, ... Aids 19 (6), 593-601, 2005 | 757 | 2005 |
| Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy JK Rockstroh, A Mocroft, V Soriano, C Tural, MH Losso, A Horban, O Kirk, ... The Journal of infectious diseases 192 (6), 992-1002, 2005 | 559 | 2005 |
| Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe A Mocroft, O Kirk, SE Barton, M Dietrich, R Proenca, R Colebunders, ... Aids 13 (8), 943-950, 1999 | 553 | 1999 |
| Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ... Aids 24 (11), 1667-1678, 2010 | 546 | 2010 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 471 | 2010 |
| Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? E Fontas, F Van Leth, CA Sabin, N Friis-Møller, M Rickenbach, ... The Journal of infectious diseases 189 (6), 1056-1074, 2004 | 432 | 2004 |
| Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study … A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ... PLoS medicine 10 (9), e1001510, 2013 | 402 | 2013 |
| HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load AN Phillips, S Staszewski, R Weber, O Kirk, P Francioli, V Miller, ... Jama 286 (20), 2560-2567, 2001 | 391 | 2001 |
| Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ... The Journal of infectious diseases 207 (9), 1359-1369, 2013 | 380 | 2013 |
| Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy O Kirk, C Pedersen, A Cozzi-Lepri, F Antunes, V Miller, JM Gatell, ... Blood, The Journal of the American Society of Hematology 98 (12), 3406-3412, 2001 | 350 | 2001 |
| Serious fatal and nonfatal non-AIDS-defining illnesses in Europe A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010 | 344 | 2010 |
| Changing incidence of central nervous system diseases in the EuroSIDA cohort A d'Arminio Monforte, P Cinque, A Mocroft, FD Goebel, F Antunes, ... Annals of Neurology: Official Journal of the American Neurological …, 2004 | 334 | 2004 |
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort … Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... International journal of epidemiology 41 (2), 433-445, 2012 | 325 | 2012 |
| Influence of age on CD4 cell recovery in human immunodeficiency virus–infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study JP Viard, A Mocroft, A Chiesi, O Kirk, B Røge, G Panos, N Vetter, ... The Journal of infectious diseases 183 (8), 1290-1294, 2001 | 320 | 2001 |
| Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection GJ Weverling, A Mocroft, B Ledergerber, O Kirk, J Gonzales-Lahoz, ... The Lancet 353 (9161), 1293-1298, 1999 | 310 | 1999 |
| Chronic renal failure among HIV-1-infected patients A Mocroft, O Kirk, J Gatell, P Reiss, P Gargalianos, K Zilmer, M Beniowski, ... Aids 21 (9), 1119-1127, 2007 | 300 | 2007 |
